Remedy Robotics Raises $62M Series B to Push Stroke Robot Toward FDA
Remedy Robotics raised $62M in a DCVC-led Series B to advance its AI-enabled N1 stroke-intervention robot toward UC clinical trials and potential FDA approval.
Topic
Topic
Remedy Robotics raised $62M in a DCVC-led Series B to advance its AI-enabled N1 stroke-intervention robot toward UC clinical trials and potential FDA approval.